Memory-chip leader Micron is the IBD Stock Of The Day as the company benefits from the buildout of AI data centers.

A global consensus overrides fear of harming the fetus and makes some novel recommendations for the use of medication during ...

IBD 50 stock Guardant HealthGH took a tumble Thursday after the company's second-generation colon cancer test lagged ...

A retrospective study finds that rates of malnutrition and other adverse clinical outcomes are higher 1 month before surgery ...

The OMass partnership will boost Roche’s strategy in inflammatory bowel diseases, currently led by afimkibart, an anti-TL1A ...

Researchers sought to identify the pooled prevalence and to better describe the bidirectional relationship between IBD and autoimmune liver disease.

Boomerang Medical announced today that it raised $20 million in a Series B financing to support its implantable ...

Roche’s Genentech unit has handed over $20 million in upfront cash for the license to Omass Therapeutics’ preclinical inflammatory bowel disease (IBD) program. | Roche’s Genentech unit has handed over ...

Inflammatory bowel disease, or IBD, is an umbrella term for a group of chronic conditions that cause inflammation and ...

Live audio webcasts and replays of these events will be available on the Spyre investor events website at https://ir.spyre.com/news-events/events.

The group of rapidly expanding firms includes mainstays like LPL Financial, but also smaller upstarts that are enlarging ...